Lipocine (LPCN) Share-based Compensation (2012 - 2025)
Lipocine's Share-based Compensation came in at $53,256 for Q3 2025, down 50.6% from $107,894 a year earlier and down 18.3% from the prior quarter.
Powered by 
Analysis
Lipocine (LPCN) Share-based Compensation (2012 - 2025) Analysis & Trends
Over the trailing twelve months to Sep 30, 2025, Lipocine reported Share-based Compensation of $288,549, down 37.7% year-over-year; for FY2024, it came in at $408,551, down 37.6% from FY2023.
- Share-based Compensation carries a five-year compound annual growth rate of -17.0% (FY2019 to FY2024).
- Going back by year, Share-based Compensation was $654,438 in FY2023 (+2.9%), $636,140 in FY2022 (+5.3%), $603,946 in FY2021 (-56.0%) and $1.37 million in FY2020 (+32.6%).
- The Q3 2025 figure represents the lowest quarterly Share-based Compensation since Q4 2012.
- Year-over-year, Share-based Compensation has declined for nine consecutive quarters, with an average decline of 34.0% over the last eight quarters.
- The fastest year-over-year change in Share-based Compensation over five years came in Q2 2023 (growth of 17.9%), and the weakest in Q2 2021 (a decline of 68.4%).
- Business Quant data shows LPCN's Share-based Compensation at $65,205 (Q2 2025), $71,002 (Q1 2025) and $99,086 (Q4 2024) in the three quarters before Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 458.00 Mn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 166.00 Mn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 298.00 Mn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | - |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 165.00 Mn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 231.00 Mn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 249.00 Mn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 170.20 Mn |
| 10 | Lipocine | 11.33 Mn | -56.39 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2025 | 53,256.00 |
| Jun 30, 2025 | 65,205.00 |
| Mar 31, 2025 | 71,002.00 |
| Dec 31, 2024 | 99,086.00 |
| Sep 30, 2024 | 107,894.00 |
| Jun 30, 2024 | 102,265.00 |
| Mar 31, 2024 | 99,306.00 |
| Dec 31, 2023 | 153,438.00 |
| Sep 30, 2023 | 158,090.00 |
| Jun 30, 2023 | 165,000.00 |
| Mar 31, 2023 | 178,000.00 |
| Dec 31, 2022 | 165,140.00 |
| Sep 30, 2022 | 160,227.00 |
| Jun 30, 2022 | 140,000.00 |
| Mar 31, 2022 | 171,028.00 |
| Dec 31, 2021 | 154,635.00 |
| Sep 30, 2021 | 155,000.00 |
| Jun 30, 2021 | 147,000.00 |
| Mar 31, 2021 | 148,000.00 |
| Dec 31, 2020 | 234,588.00 |
API Access
Lipocine Share-based Compensation API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=share-based-compensation&ticker=LPCN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "share-based-compensation", "ticker": "LPCN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=share-based-compensation&ticker=LPCN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();